000 01247 a2200373 4500
005 20250512020445.0
264 0 _c19890803
008 198908s 0 0 eng d
022 _a0008-5472
040 _aNLM
_beng
_cNLM
100 1 _aWeiner, L M
245 0 0 _aPhase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.
_h[electronic resource]
260 _bCancer research
_cJul 1989
300 _a4062-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aImmunotoxins
_xadverse effects
650 0 4 _aNeoplasm Metastasis
650 0 4 _aRecombinant Proteins
_xadverse effects
650 0 4 _aRicin
_xadverse effects
700 1 _aO'Dwyer, J
700 1 _aKitson, J
700 1 _aComis, R L
700 1 _aFrankel, A E
700 1 _aBauer, R J
700 1 _aKonrad, M S
700 1 _aGroves, E S
773 0 _tCancer research
_gvol. 49
_gno. 14
_gp. 4062-7
999 _c2792617
_d2792617